ClinConnect ClinConnect Logo
Search / Trial NCT06669468

Comparison of the Efficacy of Perineal and Anal Electrical Stimulation in Patients with Urinary Incontinence After Radical Prostatectomy

Launched by PAMUKKALE UNIVERSITY · Oct 31, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Anal Electrical Stimulation Perineal Electrical Stimulation Radical Prostatectomy İncontinence

ClinConnect Summary

This clinical trial is studying two types of electrical stimulation treatments—perineal and anal stimulation—to see which one helps men better manage urinary incontinence (UI) after they have had prostate surgery (radical prostatectomy). The goal is to find out if adding these treatments to pelvic floor muscle exercises can improve issues related to urinary control, quality of life, and even emotional well-being like anxiety and depression.

To participate, men aged 18 to 80 who have experienced urinary incontinence after their surgery and are willing to commit to the study will be eligible. They should have been out of surgery for at least one month but less than a year. Participants will receive treatment and be asked about their experiences, including how satisfied they are with the treatment and any discomfort they might feel. This trial is important as it aims to provide new insights into effective treatments for urinary incontinence, a common issue that affects many men after prostate surgery.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 18-80 years old
  • Men with RP with incontinence over \>50 g/24 h and no residual cancer after RP on pathological examination
  • Men within 1 month to 1 year after catheter removal
  • Willingness to complete and do the QoL scale.
  • Understanding procedures, benefits, and possible side effects.
  • Being able to give written, informed consent.
  • Exclusion Criteria:
  • UI history before RP.
  • History of conservative treatment after RP including ES.
  • Prolonged indwelling urethral catheterization (more than 15 days).
  • Previous urological surgery history.
  • Men receiving radiotherapy.
  • Presence of urethral stricture and urinary tract infection.
  • Heart failure, presence of a pacemaker, implanted defibrillator.
  • Transurethral resection of the prostate due to benign prostatic hyperplasia.
  • Use of drugs that may affect bladder function (antimuscarinic, duloxetine, tricyclic antidepressant, etc.).

About Pamukkale University

Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.

Locations

Denizli, , Turkey

Patients applied

0 patients applied

Trial Officials

Necmettin YILDIZ Prof.

Study Director

Pamukkale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported